Related Experiment Video
Updated: Aug 19, 2026

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
Factors affecting development of rifampicin resistance in biofilm-producing Staphylococcus epidermidis
E Svensson1, H Hanberger, M Nilsson
1Department of Clinical Microbiology, Faculty of Health Sciences, University Hospital, Linköping, Sweden.
Abstract:
Selection and regrowth of variants resistant to 0.016-32 mg/L of rifampicin, which were present at a frequency of 10(-7) in the initial inoculum, were seen when large inocula (> 10(5) cfu/mL) of Staphylococcus epidermidis ATCC 35984 were incubated with the drug. Conventional MIC determinations using approximately 10(5) cfu/mL did not detect the resistant variants. Larger inocula increased the MIC by > 8000-fold. Population analysis showed that rifampicin concentrations above the MIC (measured at an inoculum of approximately 10(5) cfu/mL) select highly resistant variants (MIC > 256 mg/L) when large inocula (> or = 10(5) cfu/mL) were incubated with rifampicin. The resistant variants were stable through ten passages. It was not possible to prevent regrowth of the resistant variants by increasing the rifampicin concentration further. At subinhibitory concentrations there was no development of rifampicin resistance.
Related Concept Videos
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

